Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

Abida, Wassim ; Patnaik, Akash ; Campbell, David ; Shapiro, Jeremy ; Bryce, Alan H ; McDermott, Ray ; Sautois, Brieuc ; Vogelzang, Nicholas J ; Bambury, Richard M ; Voog, Eric ; Zhang, Jingsong ; Piulats, Josep M ; Ryan, Charles J ; Merseburger, Axel S ; Daugaard, Gedske ; Heidenreich, Axel ; Fizazi, Karim ; Higano, Celestia S ; Krieger, Laurence E ; Sternberg, Cora N ; Watkins, Simon P ; Despain, Darrin ; Simmons, Andrew D ; Loehr, Andrea ; Dowson, Melanie ; Golsorkhi, Tony ; Chowdhury, Simon

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3763-3772 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

Morris, Michael J ; Heller, Glenn ; Hillman, David W ; Bobek, Olivia ; Ryan, Charles ; Antonarakis, Emmanuel S ; Bryce, Alan H ; Hahn, Olwen ; Beltran, Himisha ; Armstrong, Andrew J ; Schwartz, Lawrence ; Lewis, Lionel D ; Beumer, Jan H ; Langevin, Brooke ; McGary, Eric C ; Mehan, Paul T ; Goldkorn, Amir ; Roth, Bruce J ; Xiao, Han ; Watt, Colleen ; Taplin, Mary-Ellen ; Halabi, Susan ; Small, Eric J

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3352-3362 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Intermittent abiraterone-acetate administration protocol and prognosis prediction for castrate-resistant prostate cancer

Morken, Jason David ; Cherington, Chad ; Bryce, Alan H. ; Kuang, Yang

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.353-353 [Periódico revisado por pares]

Texto completo disponível

Multiplatform biomarker analysis on non-sun exposed mucosal melanoma

Bryce, Alan H. ; Arguello, David ; Millis, Sherri Z. ; Bender, Ryan ; Reddy, Sandeep K. ; Gatalica, Zoran ; Gonzalez, Rene

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.9042-9042 [Periódico revisado por pares]

Texto completo disponível

A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer

Dhawan, Mallika Sachdev ; Lee, Mina ; Bryce, Alan H. ; Weinberg, Vivian K. ; Ryan, Charles J. ; Derleth, Christina Louise ; Harzstark, Andrea Lynne ; Small, Eric Jay ; Aggarwal, Rahul Raj

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.202-202 [Periódico revisado por pares]

Texto completo disponível

Predictors for survival after radium-223 (R223) treatment for castration-resistant metastatic prostate cancer

Anderson, Eric ; Wong, William ; Mohammadi, Homan ; Daniels, Thomas Backus ; Tzou, Katherine S. ; Schild, Steven E. ; Keole, Sameer R ; Choo, Richard ; Bryce, Alan H. ; Ho, Thai Huu ; Quevedo, Fernando ; Vora, Sujay A.

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16521-e16521 [Periódico revisado por pares]

Texto completo disponível

A multicenter phase I study of cabazitaxel (Cbz), mitoxantrone (Mito), and prednisone (Pred) (CAMP) for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC)

Aggarwal, Rahul Raj ; Bryce, Alan H. ; Weinberg, Vivian K. ; Ryan, Charles J. ; Derleth, Christina Louise ; Harzstark, Andrea ; Lee, Mina ; Small, Eric Jay

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.238-238 [Periódico revisado por pares]

Texto completo disponível

Assessment of treatment response to immunotherapy in melanoma patients with pathogenic mutations of NRAS, BRAF, CDKN2A and P53

DeLeon, Thomas ; Kipp, Benjamin ; Langlais, Blake ; Flotte, Thomas ; Winters, Jennifer ; Kosiorek, Heidi E. ; Joseph, Richard Wayne ; Markovic, Svetomir ; Dronca, Roxana Stefania ; Block, Matthew Stephen ; McWilliams, Robert R. ; Kottschade, Lisa A. ; Borad, Mitesh J. ; Rumilla, Kandelaria M. ; Voss, Jesse S ; Bryce, Alan H.

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e21057-e21057 [Periódico revisado por pares]

Texto completo disponível

Genome-wide analysis of metastases to reveal association of pathway activation with abiraterone acetate/prednisone (AA/P) primary resistance and cell cycle proliferation pathway activation with response duration in metastatic castrate resistant prostate cancer (mCRPC)

Kohli, Manish ; Wang, Liewei ; Dehm, Scott ; Hillman, David W. ; Sicotte, Hugues ; Gormley, Michael ; Bhargava, Vipul ; Li, Weimin ; Tan, Winston ; Pitot, Henry C. ; Ho, Thai Huu ; Costello, Brian Addis ; Bryce, Alan H. ; Zhenqing, Ye ; Vedell, Peter T ; Barman, Poulami ; Jimenez, Rafael E. ; Carlson, Rachel ; Wang, Liguo

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5053-5053 [Periódico revisado por pares]

Texto completo disponível

Investigator-initiated pilot study of bicalutamide and raloxifene in hormone-resistant prostate cancer

Ho, Thai Huu ; Northfelt, Donald W. ; Nateras, Rafael Nunez ; Bryce, Alan H. ; Dueck, Amylou C. ; Castle, Erik P.

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e16065-e16065 [Periódico revisado por pares]

Texto completo disponível